Dental CAD-CAM Market to grow by USD 845.8 million (2024-2028), driven by rising demand for cosmetic dental surgeries and AI driven market transformation- Technavio 
Qure.ai Taps Former GE Healthcare Exec as Chief Commercial Officer
NEW YORK, March 7, 2019 /PRNewswire/ -- Qure.ai (http://www.qure.ai), a leading healthcare AI company, today announced Chiranjiv Singh has joined...
Elsevier Launches Assessment Capabilities on Its All-new ClinicalKey Student Platform
LONDON, March 7, 2019 /PRNewswire/ -- ClinicalKey Student equips medical faculty and students with the resources they need to enhance...
Stormont Vail Health Partners with Omnicell to Enhance Medication Management Strategy
MOUNTAIN VIEW, Calif., March 7, 2019 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL) today announced that Stormont Vail Health has selected Omnicell's...
Kelyniam Announces 2018 Financial Results
COLLINSVILLE, Conn., March 7, 2019 /PRNewswire/ -- Kelyniam Global, Inc., (OTC: KLYG), a manufacturer of custom cranial implants has issued a...
CorMedix Inc. to Present at Roth and Oppenheimer & Co. Investor Conferences
BERKELEY HEIGHTS, NJ / ACCESSWIRE / March 11, 2019 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on...
ENDRA Life Sciences Reports Full Year 2018 Financial & Operational Results
Management to Host Full Year 2018 Conference Call Today at 4:30 p.m. ET ANN ARBOR, MI / ACCESSWIRE / March...
Easton Commences Cannabis Edibles Division and Announces Updates on Its Filing for the Period Ended December 31, 2018
TORONTO, ON / ACCESSWIRE / March 11, 2019 / Easton Pharmaceuticals Inc. (OTC PINK: EAPH) announces that it has commenced...
Cerecor Announces Closing of $10.0 Million Bought Deal of Common Stock
ROCKVILLE, MD / ACCCESSWIRE / March 11, 2019 / Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a...
Viveve Completes Enrollment in VIVEVE II Trial
Results could support a marketing application for an expanded U.S. indication for improvement of sexual function in women ENGLEWOOD, CO...
IntraBio Clinical Trial Authorisation Application Approved by the MHRA for the treatment of Niemann-Pick Disease Type C
OXFORD, UK / ACCESSWIRE / March 11, 2019 / IntraBio Inc., a late-stage biopharmaceutical company, today announced that the UK...
ORYZON Announces FDA Approval of IND for ETHERAL, a Phase IIa trial of the Epigenetic Drug Vafidemstat in Patients with Mild to Moderate Alzheimer’s disease
Recruitment is ongoing in Europe; The European and US Study will recruit a total of 150 patients MADRID, SPAIN and...
Nevada Hemp Licence Acquired
VANCOUVER, BC / ACCESSWIRE / March 11, 2019 / EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: EVAHF) (the "Company") is...
Dr. Michael Lange’s Fortifeye Vitamins Announces Advanced Dry Eye Therapy – Sold Out In Just Three Weeks
OCALA, FL / ACCESSWIRE / March 8, 2019 / Fortifeye Vitamins announced today that its Advanced Dry Eye Therapy, which...
Paris Fashion Week – LIU CHAO 2019FW: Esprit Couture
NEW YORK, NY / ACCESSWIRE / March 8, 2019 / The young Chinese Paris - Based designer, Liu Chao, will...
NanoVibronix CEO to Present UroShield(R) at the U.S. National Institutes of Health’s Catheter-Associated Urinary Tract Infections Technology Workshop
ELMSFORD, NY / ACCESSWIRE / March 8, 2019 / NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company utilizing its proprietary...
Soliton’s RAP Device Received Institutional Review Board Approval of Non-Significant Risk Designation
HOUSTON, TX / ACCESSWIRE / March 8, 2019 / Soliton, Inc., (NASDAQ: SOLY) ("Soliton" or the "Company"), a medical device...
Oncolytics Biotech (R) Announces 2018 Year-End Results and Operational Highlights
- Recent biomarker data identifies a simple blood test that may predict clinical response to pelareorep - - AWARE-1 window...
Nephros to Present at the 2019 LD Micro Virtual Conference
LOS ANGELES, CA / ACCESSWIRE / March 7, 2019 / Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company...
NeoGenomics To Present At 39th Annual Cowen and Company Health Care Conference
FT MYERS, FL / ACCESSWIRE / March 7, 2019 / NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic...
Genmed appoints Ruth Billen as finance director
March 7, 2019 – Genmed, a specialist provider of vendor neutral managed services to the NHS, today announces the appointment...